| Lastest Insider Transactions Of ALNYLAM PHARMACEUTICALS, INC. ( ALNY ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2026-06-01 | Sell | 3,830 | 299.18 | 1,145,853 | 2026-06-03 16:25:20 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2026-06-01 | Option Exercise | 3,830 | 0.00 | 0 | 2026-06-03 16:25:20 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2026-05-13 | Option Exercise | 11,250 | 70.20 | 789,750 | 2026-05-14 16:17:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | McLaughlin Melissa | Chief Human Resources Officer | 2026-04-02 | Sell | 3,910 | 325.92 | 1,274,343 | 2026-04-07 16:21:18 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-03-04 | Sell | 4,713 | 323.53 | 1,524,796 | 2026-03-06 16:13:37 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2026-03-04 | Sell | 2,933 | 323.08 | 947,581 | 2026-03-06 16:13:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2026-03-04 | Sell | 2,468 | 323.08 | 797,351 | 2026-03-06 16:12:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2026-03-04 | Sell | 2,309 | 323.08 | 745,984 | 2026-03-06 16:12:15 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-03-04 | Sell | 1,291 | 323.54 | 417,685 | 2026-03-06 16:11:49 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2026-03-02 | Sell | 2,206 | 327.65 | 722,801 | 2026-03-04 19:31:44 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-03-02 | Sell | 3,492 | 323.63 | 1,130,132 | 2026-03-04 19:31:07 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-03-02 | Sell | 3,250 | 323.62 | 1,051,773 | 2026-03-04 19:30:38 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2026-03-02 | Sell | 1,598 | 327.65 | 523,584 | 2026-03-04 19:30:06 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2026-03-02 | Sell | 6,799 | 327.65 | 2,227,699 | 2026-03-04 19:29:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2026-02-27 | Option Exercise | 5,921 | 0.00 | 0 | 2026-03-02 16:10:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2026-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2026-03-02 16:09:41 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2026-02-27 | Option Exercise | 1,666 | 0.00 | 0 | 2026-03-02 16:09:17 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-02-27 | Sell | 4,627 | 331.34 | 1,533,100 | 2026-03-02 16:08:43 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2026-03-02 16:08:43 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-02-12 | Sell | 2,242 | 310.08 | 695,201 | 2026-02-17 19:28:48 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2026-02-12 | Sell | 6,958 | 310.08 | 2,157,542 | 2026-02-17 19:27:57 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2026-02-12 | Sell | 1,959 | 310.08 | 607,448 | 2026-02-17 19:27:24 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-02-12 | Sell | 4,000 | 321.24 | 1,284,980 | 2026-02-17 19:26:59 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2026-02-12 | Sell | 2,242 | 310.08 | 695,201 | 2026-02-17 19:26:01 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2026-01-11 | Sell | 1,510 | 362.87 | 547,929 | 2026-01-14 16:23:29 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2026-01-11 | Sell | 9,577 | 362.86 | 3,475,157 | 2026-01-14 16:23:05 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2026-01-11 | Sell | 2,780 | 362.87 | 1,008,766 | 2026-01-14 16:22:39 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2026-01-11 | Sell | 1,510 | 362.87 | 547,927 | 2026-01-14 16:22:19 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-01-11 | Sell | 3,800 | 367.37 | 1,395,992 | 2026-01-14 16:21:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-11-26 | Option Exercise | 4,697 | 106.40 | 499,756 | 2025-12-01 16:10:26 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-11-17 | Sell | 12,128 | 452.18 | 5,483,990 | 2025-11-19 16:05:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-11-17 | Option Exercise | 8,161 | 119.13 | 972,220 | 2025-11-19 16:05:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-11-12 | Sell | 25,650 | 452.75 | 11,613,003 | 2025-11-14 16:13:41 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-11-12 | Option Exercise | 25,650 | 117.18 | 3,005,693 | 2025-11-14 16:13:41 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-10-01 | Sell | 3,821 | 452.05 | 1,727,284 | 2025-10-03 17:14:56 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-10-01 | Sell | 8,924 | 452.05 | 4,034,085 | 2025-10-03 17:14:30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-10-01 | Sell | 1,405 | 452.05 | 635,126 | 2025-10-03 17:14:03 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-10-01 | Sell | 2,441 | 452.05 | 1,103,452 | 2025-10-03 17:13:08 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2025-10-01 | Sell | 5,959 | 451.76 | 2,692,062 | 2025-10-03 17:12:26 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-08-29 | Sell | 3,474 | 448.37 | 1,557,650 | 2025-09-02 16:10:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | 2025-08-15 | Sell | 2,851 | 455.89 | 1,299,746 | 2025-08-19 17:28:53 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-08-15 | Sell | 1,396 | 453.27 | 632,759 | 2025-08-19 17:28:18 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-08-15 | Sell | 2,274 | 453.27 | 1,030,727 | 2025-08-19 17:27:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-08-15 | Sell | 2,274 | 453.27 | 1,030,727 | 2025-08-19 17:27:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-08-15 | Sell | 6,979 | 453.27 | 3,163,346 | 2025-08-19 17:27:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-08-15 | Sell | 6,979 | 453.27 | 3,163,346 | 2025-08-19 17:27:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-08-15 | Sell | 1,396 | 453.27 | 632,759 | 2025-08-19 17:26:36 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-08-15 | Sell | 1,396 | 453.27 | 632,759 | 2025-08-19 17:26:36 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2025-08-18 | Sell | 11,250 | 450.00 | 5,062,500 | 2025-08-19 17:26:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2025-08-18 | Option Exercise | 11,250 | 70.20 | 789,750 | 2025-08-19 17:26:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Ausiello Dennis A | Directior | 2025-08-14 | Sell | 31,448 | 436.58 | 13,729,536 | 2025-08-15 16:05:33 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Ausiello Dennis A | Directior | 2025-08-14 | Option Exercise | 31,448 | 131.34 | 4,130,478 | 2025-08-15 16:05:33 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-05-30 | Sell | 50,937 | 305.00 | 15,535,784 | 2025-06-03 16:10:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-05-30 | Option Exercise | 50,937 | 118.56 | 6,039,207 | 2025-06-03 16:10:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2025-05-15 | Sell | 11,250 | 277.71 | 3,124,217 | 2025-05-19 16:17:09 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2025-05-15 | Option Exercise | 11,250 | 131.21 | 1,476,113 | 2025-05-19 16:17:09 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Directior | 2024-08-29 | Buy | 36 | 287.85 | 10,363 | 2025-05-12 16:05:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Directior | 2024-08-29 | Sell | 36 | 232.86 | 8,383 | 2025-05-12 16:05:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-03-21 | Sell | 9,766 | 293.36 | 2,864,985 | 2025-03-25 16:10:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-03-21 | Option Exercise | 5,445 | 42.22 | 229,888 | 2025-03-25 16:10:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2025-03-24 | Sell | 7,440 | 299.00 | 2,224,560 | 2025-03-25 16:09:47 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2025-03-24 | Option Exercise | 7,440 | 88.95 | 661,788 | 2025-03-25 16:09:47 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2025-03-13 | Option Exercise | 2,750 | 131.21 | 360,828 | 2025-03-14 16:16:13 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-03-03 | Sell | 2,755 | 242.94 | 669,304 | 2025-03-05 16:22:53 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-03-03 | Sell | 471 | 243.78 | 114,820 | 2025-03-05 16:22:22 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-03-03 | Sell | 2,557 | 242.92 | 621,150 | 2025-03-05 16:21:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-03-03 | Sell | 1,264 | 243.78 | 308,141 | 2025-03-05 16:21:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-03-03 | Sell | 3,877 | 243.79 | 945,165 | 2025-03-05 16:20:59 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-02-27 | Sell | 2,900 | 241.69 | 700,894 | 2025-03-03 16:32:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-02-27 | Option Exercise | 5,921 | 0.00 | 0 | 2025-03-03 16:32:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-27 | Sell | 796 | 241.70 | 192,390 | 2025-03-03 16:31:58 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2025-03-03 16:31:58 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-27 | Sell | 513 | 241.68 | 123,983 | 2025-03-03 16:31:31 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-27 | Option Exercise | 1,667 | 0.00 | 0 | 2025-03-03 16:31:31 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-27 | Sell | 935 | 241.69 | 225,977 | 2025-03-03 16:31:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2025-03-03 16:31:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | Sell | 496 | 241.69 | 119,878 | 2025-03-03 16:30:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2025-02-13 | Sell | 1,213 | 255.17 | 309,527 | 2025-02-18 16:49:06 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2025-02-13 | Sell | 967 | 255.17 | 246,750 | 2025-02-18 16:47:57 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-13 | Sell | 2,103 | 252.71 | 531,448 | 2025-02-18 16:47:38 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-13 | Sell | 3,109 | 253.43 | 787,904 | 2025-02-18 16:47:04 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-01-27 | Sell | 52,592 | 285.00 | 14,988,720 | 2025-01-29 16:03:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-01-27 | Option Exercise | 48,876 | 88.95 | 4,347,520 | 2025-01-29 16:03:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SHARP PHILLIP A | Directior | 2025-01-23 | Sell | 11,250 | 275.00 | 3,093,750 | 2025-01-24 16:10:44 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SHARP PHILLIP A | Directior | 2025-01-23 | Option Exercise | 11,250 | 131.21 | 1,476,113 | 2025-01-24 16:10:44 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | Sell | 1,752 | 251.00 | 439,760 | 2024-12-13 16:13:29 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-11-25 | Sell | 5,219 | 250.98 | 1,309,853 | 2024-11-27 17:22:59 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-11-25 | Sell | 1,682 | 250.98 | 422,144 | 2024-11-27 17:22:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2024-11-25 | Sell | 1,682 | 250.98 | 422,144 | 2024-11-27 17:21:37 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2024-11-25 | Sell | 1,469 | 250.98 | 368,686 | 2024-11-27 17:21:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-11-25 | Sell | 3,000 | 251.65 | 754,947 | 2024-11-27 17:20:36 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Sell | 15,000 | 280.00 | 4,200,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Option Exercise | 15,000 | 85.00 | 1,275,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Sell | 15,000 | 280.00 | 4,200,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Option Exercise | 15,000 | 85.00 | 1,275,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Sell | 15,000 | 280.00 | 4,200,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Option Exercise | 15,000 | 85.00 | 1,275,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Sell | 15,000 | 280.00 | 4,200,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-08-20 | Option Exercise | 15,000 | 85.00 | 1,275,000 | 2024-08-22 20:01:25 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-08-12 | Sell | 22,025 | 270.99 | 5,968,516 | 2024-08-14 16:12:07 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-08-12 | Option Exercise | 20,725 | 89.09 | 1,846,429 | 2024-08-14 16:12:07 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-07-11 | Sell | 7,093 | 261.00 | 1,851,273 | 2024-07-12 20:02:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2024-06-25 | Sell | 8,500 | 240.00 | 2,040,000 | 2024-06-27 16:04:53 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2024-06-25 | Option Exercise | 8,500 | 131.21 | 1,115,285 | 2024-06-27 16:04:53 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2024-06-24 | Sell | 32,450 | 220.69 | 7,161,360 | 2024-06-26 16:28:27 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2024-06-24 | Option Exercise | 32,450 | 80.76 | 2,620,611 | 2024-06-26 16:28:27 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-06-24 | Sell | 2,103 | 230.99 | 485,773 | 2024-06-26 16:28:01 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-06-24 | Sell | 8,301 | 230.99 | 1,917,475 | 2024-06-26 16:27:20 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2024-06-24 | Sell | 1,605 | 231.00 | 370,747 | 2024-06-26 16:26:51 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2024-06-24 | Sell | 1,605 | 231.00 | 370,747 | 2024-06-26 16:26:27 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-06-24 | Sell | 1,198 | 230.99 | 276,731 | 2024-06-26 16:26:03 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2024-05-29 | Sell | 21,700 | 148.60 | 3,224,546 | 2024-05-31 19:00:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2024-05-29 | Option Exercise | 30,000 | 66.83 | 2,004,900 | 2024-05-31 19:00:52 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SHARP PHILLIP A | Directior | 2024-02-29 | Sell | 30,000 | 151.34 | 4,540,071 | 2024-03-01 16:12:55 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SHARP PHILLIP A | Directior | 2024-02-29 | Option Exercise | 30,000 | 59.25 | 1,777,500 | 2024-03-01 16:12:55 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2024-02-27 | Sell | 501 | 155.30 | 77,805 | 2024-02-29 16:18:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2024-02-27 | Option Exercise | 1,667 | 0.00 | 0 | 2024-02-29 16:18:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2024-02-27 | Sell | 574 | 155.30 | 89,145 | 2024-02-29 16:18:30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2024-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2024-02-29 16:18:30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-02-27 | Sell | 2,932 | 155.31 | 455,357 | 2024-02-29 16:18:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-02-27 | Option Exercise | 5,921 | 0.00 | 0 | 2024-02-29 16:18:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-02-27 | Sell | 574 | 155.30 | 89,145 | 2024-02-29 16:17:12 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-02-27 | Option Exercise | 1,908 | 0.00 | 0 | 2024-02-29 16:17:12 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-02-15 | Sell | 1,308 | 148.06 | 193,666 | 2024-02-20 16:09:12 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2024-02-15 | Sell | 1,007 | 148.06 | 149,099 | 2024-02-20 16:08:59 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2024-02-15 | Sell | 1,009 | 148.06 | 149,397 | 2024-02-20 16:08:24 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2024-02-15 | Sell | 7,030 | 148.06 | 1,040,885 | 2024-02-20 16:07:31 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | 2024-02-01 | Sell | 1,591 | 170.99 | 272,050 | 2024-02-05 16:05:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | 2024-02-01 | Option Exercise | 5,175 | 0.00 | 0 | 2024-02-05 16:05:23 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2023-12-27 | Sell | 30,000 | 195.00 | 5,850,000 | 2023-12-29 16:03:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2023-12-27 | Option Exercise | 30,000 | 96.45 | 2,893,500 | 2023-12-29 16:03:28 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-08-03 | Sell | 7,627 | 184.78 | 1,409,306 | 2023-08-07 18:05:45 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2023-08-03 | Sell | 3,460 | 185.85 | 643,037 | 2023-08-07 18:05:19 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2023-08-03 | Sell | 4,057 | 185.85 | 753,986 | 2023-08-07 18:04:48 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Vaishnaw Akshay | President | 2023-08-03 | Sell | 4,057 | 185.85 | 753,986 | 2023-08-07 18:04:22 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2023-08-02 | Sell | 6,448 | 185.38 | 1,195,310 | 2023-08-04 16:02:49 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Directior | 2023-08-02 | Option Exercise | 22,477 | 0.00 | 0 | 2023-08-04 16:02:49 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer | 2023-04-26 | Sell | 7,615 | 194.59 | 1,481,812 | 2023-04-28 17:55:48 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | 2023-04-26 | Sell | 977 | 194.59 | 190,113 | 2023-04-28 17:55:26 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2023-04-26 | Sell | 1,476 | 194.59 | 287,215 | 2023-04-28 17:55:04 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Vaishnaw Akshay | President | 2023-04-26 | Sell | 2,392 | 194.59 | 465,464 | 2023-04-28 17:54:36 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-04-26 | Sell | 4,294 | 197.12 | 846,450 | 2023-04-28 17:54:06 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | 2023-04-06 | Sell | 3,500 | 210.00 | 735,000 | 2023-04-10 16:29:17 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-03-03 | Sell | 18,072 | 200.00 | 3,614,400 | 2023-03-07 16:07:30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-03-03 | Option Exercise | 5,000 | 96.45 | 482,250 | 2023-03-07 16:07:30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Directior | 2023-02-23 | Option Exercise | 136 | 0.00 | 0 | 2023-02-27 16:13:50 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Directior | 2023-02-23 | Option Exercise | 136 | 0.00 | 0 | 2023-02-27 16:13:02 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | HAMBURG MARGARET A | Directior | 2023-02-23 | Option Exercise | 136 | 0.00 | 0 | 2023-02-27 16:12:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fanucci Marsha | Directior | 2023-02-23 | Option Exercise | 136 | 0.00 | 0 | 2023-02-27 16:11:47 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Ausiello Dennis A | Directior | 2023-02-23 | Option Exercise | 136 | 0.00 | 0 | 2023-02-27 16:11:15 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | 2023-02-01 | Sell | 1,675 | 226.01 | 378,563 | 2023-02-03 17:46:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | 2023-02-01 | Option Exercise | 5,175 | 0.00 | 0 | 2023-02-03 17:46:11 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2023-02-01 | Sell | 5,025 | 230.19 | 1,156,692 | 2023-02-03 17:45:42 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | 2023-02-01 | Option Exercise | 5,025 | 0.00 | 0 | 2023-02-03 17:45:42 |
